Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Chemistry
Class Information
Number: 435/343.2
Name: Chemistry: molecular biology and microbiology > Animal cell, per se (e.g., cell lines, etc.); composition thereof; process of propagating, maintaining or preserving an animal cell or composition thereof; process of isolating or separating an animal cell or composition thereof; process of preparing a composition containing an animal cell; culture media therefore > Animal cell, per se, expressing immunoglobulin, antibody, or fragment thereof > Immunoglobulin or antibody binds a microorganism or normal or mutant component or product thereof (e.g., animal cell, cell surface antigen, secretory product, etc.) > Binds a hematopoietic cell or component or product thereof (e.g., erythrocyte, granulocyte, macrophage, monocyte, platelet, myelogenous leukemia cell, bone marrow stem cell, granulocytic cell surface antigen, hemoglobin, thrombospondin, glycophorin, etc.) > Binds a lymphocytic or lymphocytic-like cell or component or product thereof (e.g., b cell, b-lineage bone marrow cell, null cell, natural killer cell, b-lymphoblastoid cell, b-lineage, acute lymphoblastic leukemia cell, b-lymphocytic cell surface antigen, etc.) > Binds a t-lymphocytic cell or component or product thereof (e.g., t-cell, thymocyte, t-lineage bone marrow cell, t-lymphoblastoid cell, t-lineage acute lymphoblastic leukemia cell, t-lymphocytic cell surface antigen, etc.)
Description: Subject matter involving an animal cell which produces a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with an integral or isolated part of a T-lymphocytic cell, or with a substance shed or secreted by a T-lymphocytic cell.


Patents under this class:
1 2 3

Patent Number Title Of Patent Date Issued
7524498 Human immunomodulatory monoclonal antibodies for the treatment of cancer Apr. 28, 2009
7332582 Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency Feb. 19, 2008
7309489 Mouse CD40 ligand-specific antibodies and hybridomas Dec. 18, 2007
7259247 Anti-human T-cell costimulating polypeptide monoclonal antibodies Aug. 21, 2007
7220411 Compositions comprising anti-CCR5 antibody May. 22, 2007
7138119 Compositions and methods for inhibition of HIV-1 infection Nov. 21, 2006
7087396 Monoclonal antibody and method and kit for immunoassay of soluble human ST2 Aug. 8, 2006
7030225 Antibodies to JTT-1 protein, cells secreting such antibodies, and methods of making such antibodies Apr. 18, 2006
6987171 Human CD28 specific monoclonal antibodies for antigen-non-specific activation of T-lymphocytes Jan. 17, 2006
6893813 Methods for treatment of HIV and other infections using a T cell or viral activator and anti-retroviral combination therapy May. 17, 2005
6875609 Methods for the early diagnosis of ovarian cancer Apr. 5, 2005
6849258 LO-CD2a antibody and uses thereof for inhibiting T cell activation and proliferation Feb. 1, 2005
6803039 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM Oct. 12, 2004
6790662 Method of isolating CD8+ cells, and related hybridoma cells antibodies and polypeptides Sep. 14, 2004
6787354 Methods for the early diagnosis of ovarian cancer Sep. 7, 2004
6737059 Methods of inhibiting inflammatory processes and alleviating symptoms associated with multiple sclerosis May. 18, 2004
6689607 Human tumor, necrosis factor receptor-like proteins TR11, TR11SV1 and TR11SV2 Feb. 10, 2004
6685947 T helper cell epitopes Feb. 3, 2004
6602503 Recombinant anti-VLA-4 antibody molecules Aug. 5, 2003
6596536 Nucleotide sequences coding for variable regions of the alpha chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses Jul. 22, 2003
6541611 LO-CD2b antibody Apr. 1, 2003
6514758 Methods for treatment of HIV and other infections using A T cell or viral activator and anti-retroviral combination therapy Feb. 4, 2003
6515111 Monoclonal antibody which inhibits transendothelial migration of human mononuclear leukocytes Feb. 4, 2003
6511665 Antibodies to interleukin-1 receptors Jan. 28, 2003
6498006 Methods for treatment of HIV and other infections using A T cell or viral activator and anti-retroviral combination therapy Dec. 24, 2002
6485970 Immunointeractive antibody Nov. 26, 2002
6482598 Antibody recognizing a small subset of human hematopoietic cells Nov. 19, 2002
6403091 Methods for inhibiting the rejection of a transplant organ in a subject with 5C8-specific antibodies Jun. 11, 2002
6365404 Hematopoietic cell method for treatment of HIV infection Apr. 2, 2002
6365343 Intercellular adhesion molecule powder formulation Apr. 2, 2002
6352832 Anti-CCR2 antibodies and methods of use therefor Mar. 5, 2002
6331615 Nucleic acid molecule encoding heavy or light chain of an antibody which specifically recognizes a protein specifically recognized by monoclonal antibody 5c8 (anti-CD40 ligand) Dec. 18, 2001
6316257 Modified rapid expansion methods ("modified-REM") for in vitro propagation of T lymphocytes Nov. 13, 2001
6312692 Method of treating graft-versus-host disease with anti-GP39 antibodies and bone marrow cells Nov. 6, 2001
6300090 Methods of use of viral vectors to deliver antigen to dendritic cells Oct. 9, 2001
6287569 Vaccines with enhanced intracellular processing Sep. 11, 2001
6280957 Costimulatory blockade and mixed chimerism in allo-transplantation Aug. 28, 2001
6274347 Method of producing a cell surface bound lam-1 specific antibody Aug. 14, 2001
6271028 Hematopoietic cell method for treatment of HIV infection Aug. 7, 2001
6268214 Vectors encoding a modified low affinity nerve growth factor receptor Jul. 31, 2001
6242579 Antigen found on a small subset of human hematopoietic cells which binds to monoclonal antibody MG1 Jun. 5, 2001
6242176 Papillomavirus cellular receptor Jun. 5, 2001
6235525 Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof May. 22, 2001
6232088 Treatment and prevention of immune rejection reactions May. 15, 2001
6225117 Antibodies against human IL-12 May. 1, 2001
6210671 Humanized antibodies reactive with L-selectin Apr. 3, 2001
6207156 Specific antibodies and antibody fragments Mar. 27, 2001
6190863 Sugar chain-recognizing antibodies and remedies for HIV infectious diseases Feb. 20, 2001
6166186 Monoclonal antibody which binds to a human-Th2-specific protein and hybridoma Dec. 26, 2000
6156307 Immortalization of dendritic cells with v-myc oncogene Dec. 5, 2000

1 2 3


 
 
  Recently Added Patents
Method, system and program products for reducing data movement within a computing environment
System and method for queueing and moderating group talk
Sanitary wipe container
Wideband multiple access telecommunication method and apparatus
Supports for fuel cell catalysts
Purge gas streams to stagnant zones within oxygenate-to-olefin reactor
Semiconductor device and method of driving semiconductor device
  Randomly Featured Patents
Convertible highway-railway hauling vehicle
Bipolar power transistor having bypassable incorporated-base ballast resistance
Portable computer
Drop-out detection circuit
Selective solder bump application
Twin-shell vehicle door with double-strand cable window lift mechanism pre-fitted on a support plate
Electronic binoculars
Color processing method, and system with coverage restriction
Recording disk drive
Process for preparing 4-substituted imidazole compounds